middle.news
EMVision Surpasses 200 Patients in emu™ Brain Scanner Trial
8:28am on Monday 31st of August, 2026 AEST
•
Healthcare
Read Story
EMVision Surpasses 200 Patients in emu™ Brain Scanner Trial
8:28am on Monday 31st of August, 2026 AEST
Key Points
emu™ trial recruitment exceeds 200 patients
No device-related adverse events reported
FDA engagement progressing on acute ischaemia endpoint
Mayo Clinic to present early trial findings
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emvision Medical Devices (ASX:EMV)
OPEN ARTICLE